GSK-201682

Study Sponsor: GSK

Study Title

A randomized, double-blind, placebo controlled study to evaluate the safety, tolerability and clinical effect of oral danirixin (GSK1325756) in the treatment of healthy adults with acute, uncomplicated influenza (201682)

Medicine or Vaccine (generic name)

danirixin

Sponsor Identification Number

201682

Trial Registry Identification Number(#'s)

NCT02469298

Medical Condition

Virus Diseases

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=201682

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02469298

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2019